| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |